Calreticulin is able to prevent the anti-metastatic effects of estrogen receptor α (ERα) in breast cancer [29], induce cell migration and wound healing [32], as well as affect apoptosis through the regulation of calcium stores of the cell [11, 33, 34]. This evidence concerns the gene ESR1 and breast carcinoma.